DAA treatment regimen according to genotype
| Treatment regimen | Genotype 1 (%) | Genotype 2 (%) | Genotype 3(%) | Genotype 4 (%) |
| SOF/LED | 85 | – | – | 50 |
| SOF/VEL | 9 | 26 | 22 | – |
| SOF/DAC | 3 | – | 78 | – |
| SOF/RIB | – | 74 | – | – |
| ELB/GRA | – | – | – | 50 |
| OMB/PAR/DAS | 3 | – | – | – |
DAA, direct- acting antiviral agent; DAC, daclatasvir; DAS, dasabuvir; ELB, elbasvir; GRA, grazoprevir; LED, ledispavir; OMB, ombitasvir; PAR, paritaprevir; RIB, ribavirin; SOF, sofosbuvir; VEL, velapatasvir.